Reconstruction of a rare case of bilateral juvenile gigantomastia at a tertiary hospital: a case report Authors: Edouard K. Rugendabanga, Gauthier B. Murhula, Laura Pompermaier Published: 2026 ABSTRACT Introduction:Juvenile gigantomastia is a rare benign breast pathology that predominantly affects adolescents and women younger than 18 years of age. It is characterized by excessive, diffuse enlargement of the breast tissue (more than 1.5–2.5 kg per breast or constituting over 3% of total body weight), involving both glandular and stromal components. The histological picture consists of a juvenile fibroadenoma (JFA), which represents a distinct subtype of fibroepithelial breast tumor. The condition can cause severe physical discomfort, pain, posture abnormalities, recurrent skin infections, difficulties with mobility and personal hygiene, low self-esteem, and social stigma.Case presentation:A 15-year-old female presented with a 1-year history of progressive bilateral breast enlargement without nipple discharge, systemic symptoms, or trauma. On local examination, the breasts were grossly enlarged, soft, and non-tender on palpation, with the skin overstretched and visible ulcerations. Modified Goldilocks reduction mammoplasty was performed after excluding other pathologies through a breast ultrasound and hormonology report. Histology reported JFA.Discussion:JFA is a rare form of benign breast tumor, which manifests during puberty and leads to excessive breast development (gigantomastia) and its related discomfort. It is hypothesized that the causes are due to hypersensitivity of breast tissue to normal circulating estrogens, and hormonal therapy has been reported as a possible treatment, but surgery is considered the definitive treatment. Counseling on follow-up plans should be done to detect complications and recurrence.Conclusion:JFA patients seek care for physical disability and psychological distress. Surgical intervention is the definitive treatment, and histology confirms the diagnosis. Introduction Between the fourth and sixth weeks of embryonic life, ectodermal cells proliferate and migrate from the axilla to the groin with the underlying mesenchymal tissue, forming bilateral mammary ridges (milk lines)[1–3]. By approximately the 10th gestational week, the cranial and caudal portions of these ridges undergo programmed regression, with only the pectoral segment persisting to form the primordial breast[2,3]. The epithelial invaginations of the residual ridge give rise to lactiferous ducts and rudimentary mammary glands, while the surrounding mesenchyme differentiates into the fibro-fatty stromal components of the breast[3].HIGHLIGHTSThis case contributes to the limited global literature on juvenile fibroadenoma (JFA).Diagnostic confirmation: Histology revealed JFA with intra- and pericanalicular proliferation, with no atypia or malignancy.Low-and middle-income country context: Highlights follow-up challenges due to financial constraints in low- and middle-income countries, with patients lost to scheduled quarterly visits.Clinical impact: Marked improvement in physical symptoms (pain, ulceration, and dyssomnia) and self-esteem immediately postoperatively.Rare presentation, especially at a very young age of the patient. HIGHLIGHTS This case contributes to the limited global literature on juvenile fibroadenoma (JFA). This case contributes to the limited global literature on juvenile fibroadenoma (JFA). Diagnostic confirmation: Histology revealed JFA with intra- and pericanalicular proliferation, with no atypia or malignancy. Diagnostic confirmation: Histology revealed JFA with intra- and pericanalicular proliferation, with no atypia or malignancy. Low-and middle-income country context: Highlights follow-up challenges due to financial constraints in low- and middle-income countries, with patients lost to scheduled quarterly visits. Low-and middle-income country context: Highlights follow-up challenges due to financial constraints in low- and middle-income countries, with patients lost to scheduled quarterly visits. Clinical impact: Marked improvement in physical symptoms (pain, ulceration, and dyssomnia) and self-esteem immediately postoperatively. Clinical impact: Marked improvement in physical symptoms (pain, ulceration, and dyssomnia) and self-esteem immediately postoperatively. Rare presentation, especially at a very young age of the patient. Rare presentation, especially at a very young age of the patient. Subsequent breast development is under the influence of a complex interplay of endocrine signals. Additional hormones, including growth hormone, insulin, thyroxine, and adrenocortical steroids, contribute to mammary morphogenesis both in utero and during adolescence. At puberty, estrogen mediates adipogenesis and ductal proliferation, while progesterone promotes lobulo-alveolar differentiation, including areolar and lobar expansion[3,4]. The etiology is hypothesized to involve end-organ hypersensitivity to circulating estrogens or localized autocrine/paracrine hormone production within the breast tissue. Clinically, massive breast enlargement (gigantomastia) may result in mastalgia, mechanical stretching of the areolae, and cutaneous complications, including necrosis, intertriginous dermatitis, and ulceration. Chronic biomechanical stress can lead to cervical and thoracic spine strain, kyphosis, scapular winging, and, in severe cases, restrictive pulmonary symptoms. The psychological burden may be profound, with reports of depression, anxiety, and disordered eating behaviors, such as anorexia nervosa or bulimia nervosa, particularly among adolescents and young women[5,6]. Globally, juvenile fibroadenoma (JFA) is quite uncommon, with reported estimates of less than 1 in 100 000 female adolescents. Reviews from the early 1990s identified fewer than 70 documented cases worldwide; more recent counts cite around 57–70 published cases of juvenile breast hypertrophy[7]. We present, through this paper, the case of a 15-year-old girl suffering from juvenile gigantomastia, managed by modified Goldilocks reduction mammoplasty at the plastic surgery unit in a tertiary hospital in Tanzania. Methods This case report was prepared following the SCARE Guidelines for reporting surgical case reports to ensure completeness and transparency in reporting[8]. Case presentation A 15-year-old female presented with a 1-year history of progressive bilateral breast enlargement, Dallé-Dufour grade III, at a tertiary hospital in Tanzania. Her menarche occurred at age 14, followed by oligomenorrhea, with only two menstrual episodes spaced a year apart. The condition began with gradual growth but progressed to rapid hypertrophy, resulting in severe functional impairment. The patient reported constant breast pain, postural difficulty, back pain, dyssomnia, and the recent development of ulcerative skin lesions over the breasts. There was no history of nipple discharge, systemic symptoms (e.g., fever, weight loss, and night sweats), or trauma. She was the third of six siblings, with no family history of similar conditions. On local examination, the breasts were grossly enlarged; the distance between the sternal notch and the nipple was 53 cm on the right and 52 cm on the left. The overlying skin was overstretched with visible ulcerations (Figure 1). Palpation revealed soft, non-tender tissue. Hormonal serum levels of estradiol, progesterone, testosterone, follicle-stimulating hormone, and luteinizing hormone were normal, while the prolactin level was elevated (Table 1). The urinary pregnancy test was negative. Breast ultrasonography revealed bilateral, diffuse fibroadenomatous changes extending from the retro-areolar to posterior mammary zones, without encapsulated masses. A decision was made to treat the gigantomastia with breast reduction surgery after thoroughly informing the patient and her parents about the potential risks and consequences of the procedure, such as breastfeeding incapacity, numbness of the breast, and recurrence of hypertrophy. Figure 1.Preoperative pictures. Table 1Laboratory parameters.Labs investigationValuesNorrnal rangeHemoglobin10.2 g/dL12.0–15.5 g/dLEstradiol35 pg/mL20–350 pg/mlProgesterone0.1 ng/mL<1.5 ng/mlTestosterone0.54 mmol/L15–70 ng/dLProlactin (elevated)36.93 ng/mL2–25 ng/mLFollicle-stimulating hormone (FSH)3.67 mIU/mL3–10 mIU/mLLuteinizing hormone (LH)2.20 mIU/mL2–15 mIU/mL Preoperative pictures. Table 1Laboratory parameters.Labs investigationValuesNorrnal rangeHemoglobin10.2 g/dL12.0–15.5 g/dLEstradiol35 pg/mL20–350 pg/mlProgesterone0.1 ng/mL<1.5 ng/mlTestosterone0.54 mmol/L15–70 ng/dLProlactin (elevated)36.93 ng/mL2–25 ng/mLFollicle-stimulating hormone (FSH)3.67 mIU/mL3–10 mIU/mLLuteinizing hormone (LH)2.20 mIU/mL2–15 mIU/mL Laboratory parameters. A month after the presentation at the Plastic Surgery Unit (Table 2), the patient underwent bilateral breast reduction with immediate breast reconstruction using a modified Goldilocks technique and free nipple grafting. An inferior-based dermal flap was utilized to optimize symmetry and esthetic outcomes. Preoperative markings included the breast meridian, inframammary fold, and inverted-T pattern. Table 2Timetable of case events.Time pointEvent12 months before presentationOnset of progressive bilateral breast enlargement (initially gradual, later rapid)Age 14 yearsMenarche (first menstrual period)14–15 yearsOligomenorrhea (only two menstrual episodes, spaced 1 year apart)Day 0PresentationDay 0–3Clinical examination, imaging, and lab investigation~1 monthSurgeryDay 1–10 (postoperative)Inpatient recovery with suction drains; first dressing change on postoperative day 2Day 10 post-surgeryHospital discharge~7 monthsPatient was contacted through mobile device and did not report any complication Table 2Timetable of case events.Time pointEvent12 months before presentationOnset of progressive bilateral breast enlargement (initially gradual, later rapid)Age 14 yearsMenarche (first menstrual period)14–15 yearsOligomenorrhea (only two menstrual episodes, spaced 1 year apart)Day 0PresentationDay 0–3Clinical examination, imaging, and lab investigation~1 monthSurgeryDay 1–10 (postoperative)Inpatient recovery with suction drains; first dressing change on postoperative day 2Day 10 post-surgeryHospital discharge~7 monthsPatient was contacted through mobile device and did not report any complication Timetable of case events. Following de-epithelialization of the inferior dermal flap and excision of the nipple–areolar complex (NAC) as a full-thickness graft, incisions were made along the inverted-T. Bilateral multinodular tumors, each measuring approximately 47 × 45 × 20 cm and weighing around 5 kg, were surgically excised – amounting to a total tumor weight of nearly 10 kg. The de-epithelialized inferior skin flap (~1 cm thick with minimal subcutaneous fat) was molded to create conical breast volume for auto-augmentation. The superior flaps were secured to achieve the inverted-T closure with a 9-cm vertical scar. The new NAC position was marked with a 36-mm template, followed by inset and fixation of the full-thickness NAC grafts. Layered wound closure was performed with 3-0 Vicryl for deep dermal sutures and 3-0/5-0 monofilament for subcuticular closure (Figs 2 and 3). Suction drains were inserted bilaterally. No postoperative complication was encountered, classified as grade 1 Clavien-Dindo. Figure 2.Intraoperative pictures. Figure 3.Post-operative pictures. Intraoperative pictures. Post-operative pictures. The microscopic analysis of resected tissue revealed intra- and pericanalicular proliferation without evidence of atypia or malignancy, consistent with a diagnosis of JFA. The duration of the hospital stay was 10 days, and no complications were observed during this time. The first change of dressing was performed 2 days after the surgery. On that occasion, the patient was able to see the result of the operation, reporting improved self-esteem. Following a 2-week outpatient follow-up, a trimestral follow-up plan was established. Unfortunately, due to financial constraints, she has not attended any of the scheduled follow-up visits. Discussion JFA is a rare and poorly understood clinical entity, with fewer than 100 cases described in the literature to date[7]. Its pathogenesis remains elusive; however, the prevailing hypothesis implicates an exaggerated end-organ response of breast tissue to normal circulating levels of estrogens and other hormones[4,5]. This mechanism is supported by the absence of consistent endocrine abnormalities in reported cases, including our patient, whose hormonal profile was largely unremarkable, aside from mild hyperprolactinemia. Familial clustering has been documented, suggesting a possible genetic predisposition, though no definitive inheritance pattern has been identified[4,9]. In this case, no history of familial breast disorders was reported. The clinical sequelae of juvenile gigantomastia extend beyond esthetic concerns. Our patient developed significant musculoskeletal impairment, cutaneous ulceration, mastalgia, and dyssomnia, all of which are consistent with prior reports[5,6]. These complications highlight the condition’s debilitating impact on physical health, while the psychological burden – manifesting as social withdrawal, low self-esteem, anxiety, and disordered eating – has been equally emphasized in the literature, particularly among adolescents[6,10]. Early recognition and timely intervention are therefore essential to mitigate long-term morbidity. The primary surgical debate centers on reduction-mammoplasty versus mastectomy with breast reconstruction (Table 3). Reduction-mammoplasty, including the modified Goldilocks technique employed in this case, allows for preservation of part of the native breast tissue and improved cosmesis but carries a risk of recurrence, reported in up to 50% of the cases[5,7]. Conversely, mastectomy with autologous or implant-based reconstruction offers definitive management with minimal recurrence risk, yet it is associated with greater psychosocial and developmental concerns in adolescents[7]. The decision to perform wide local excision with auto-augmentation and free nipple grafting was made together with the patient and her parents, considering her young age, her wish to preserve breast tissue, and the need to balance symmetry, function, and esthetics[11–13]. Table 3Compared with traditional reduction mammoplasty[8,14–18].FactorGoldilocks techniqueTraditional reduction mammoplastyTissue preservationUses residual dermoglandular tissue to create a new mound; no implants needed.Removes tissue, reshapes with remaining parenchyma; may require implants if inadequate volume.NAC handlingAllows free nipple grafting in massive hypertrophy cases where pedicle viability is doubtful.Usually relies on pedicle techniques; risk of NAC necrosis if breast is very large.Aesthetics in massive hypertrophyBetter contour in extreme hypertrophy since tissue is rearranged autologously.Esthetics may be compromised in massive resections.Recurrence riskSimilar recurrence risk since residual breast tissue remains.Similar; recurrence risk depends on hormonal factors. Table 3Compared with traditional reduction mammoplasty[8,14–18].FactorGoldilocks techniqueTraditional reduction mammoplastyTissue preservationUses residual dermoglandular tissue to create a new mound; no implants needed.Removes tissue, reshapes with remaining parenchyma; may require implants if inadequate volume.NAC handlingAllows free nipple grafting in massive hypertrophy cases where pedicle viability is doubtful.Usually relies on pedicle techniques; risk of NAC necrosis if breast is very large.Aesthetics in massive hypertrophyBetter contour in extreme hypertrophy since tissue is rearranged autologously.Esthetics may be compromised in massive resections.Recurrence riskSimilar recurrence risk since residual breast tissue remains.Similar; recurrence risk depends on hormonal factors. Compared with traditional reduction mammoplasty[8,14–18]. Histopathological evaluation is crucial, as JFA may mimic other rapidly enlarging breast lesions such as giant fibroadenomas and phyllodes tumors[11,12,19]. Although imaging can suggest diffuse fibroadenomatous changes, definitive diagnosis relies on tissue examination, which typically reveals benign glandular hyperplasia without atypia. Histopathology in our patient showed proliferation without atypia. Follow-up is typically scheduled on a trimestral basis for up to 1 year to monitor complications and recurrence. Unfortunately, the patient did not adhere to the follow-up plan due to financial constraints. In low-and middle-income country, some patients – like ours – still do not attend scheduled follow-up visits unless they experience serious complications requiring evaluation by the surgical team. Upon discharge, patients are counseled regarding potential complications and warning signs that should prompt urgent medical consultation[20,21]. Strengths Provides a detailed, step-by-step description of the modified Goldilocks reduction mammoplasty with free nipple grafting, including preoperative markings, flap design, and layered wound closure, offering a reproducible surgical template for similar cases in resource-limited settings.While most published cases report completely normal hormonal profiles, this patient demonstrated isolated hyperprolactinemia with oligomenorrhea – an endocrinological finding not well-characterized in this condition. Provides a detailed, step-by-step description of the modified Goldilocks reduction mammoplasty with free nipple grafting, including preoperative markings, flap design, and layered wound closure, offering a reproducible surgical template for similar cases in resource-limited settings. Provides a detailed, step-by-step description of the modified Goldilocks reduction mammoplasty with free nipple grafting, including preoperative markings, flap design, and layered wound closure, offering a reproducible surgical template for similar cases in resource-limited settings. While most published cases report completely normal hormonal profiles, this patient demonstrated isolated hyperprolactinemia with oligomenorrhea – an endocrinological finding not well-characterized in this condition. While most published cases report completely normal hormonal profiles, this patient demonstrated isolated hyperprolactinemia with oligomenorrhea – an endocrinological finding not well-characterized in this condition. Limitations The patient experienced complete loss to follow-up after the 10-day postoperative visit. No preoperative breast volume measurement was obtained using formal methods, such as magnetic resonance imaging or three-dimensional scanning, relying instead on clinical examination and ultrasound.The patient’s reported improvement in self-esteem was documented anecdotally, without the use of validated psychosocial instruments such as the BREAST-Q or Rosenberg Self-Esteem Scale.As a single-institution experience from a tertiary hospital in Tanzania, the results may not be replicable in settings that lack access to specialized plastic surgery services.Poor informatics system storage is unable to store ultrasound and histopathology pictures, making us rely on the operator’s report. No preoperative breast volume measurement was obtained using formal methods, such as magnetic resonance imaging or three-dimensional scanning, relying instead on clinical examination and ultrasound. No preoperative breast volume measurement was obtained using formal methods, such as magnetic resonance imaging or three-dimensional scanning, relying instead on clinical examination and ultrasound. The patient’s reported improvement in self-esteem was documented anecdotally, without the use of validated psychosocial instruments such as the BREAST-Q or Rosenberg Self-Esteem Scale. The patient’s reported improvement in self-esteem was documented anecdotally, without the use of validated psychosocial instruments such as the BREAST-Q or Rosenberg Self-Esteem Scale. As a single-institution experience from a tertiary hospital in Tanzania, the results may not be replicable in settings that lack access to specialized plastic surgery services. As a single-institution experience from a tertiary hospital in Tanzania, the results may not be replicable in settings that lack access to specialized plastic surgery services. Poor informatics system storage is unable to store ultrasound and histopathology pictures, making us rely on the operator’s report. Poor informatics system storage is unable to store ultrasound and histopathology pictures, making us rely on the operator’s report. Conclusion Juvenile gigantomastia causes physical disability and psychological distress. Surgical reduction is an effective treatment, and histological analysis confirms the diagnosis. Recurrence risk is not negligible, and therefore, follow-up should be mandatory.